NO20065725L - En antimycobakteriell farmasoytisk sammensetning. - Google Patents

En antimycobakteriell farmasoytisk sammensetning.

Info

Publication number
NO20065725L
NO20065725L NO20065725A NO20065725A NO20065725L NO 20065725 L NO20065725 L NO 20065725L NO 20065725 A NO20065725 A NO 20065725A NO 20065725 A NO20065725 A NO 20065725A NO 20065725 L NO20065725 L NO 20065725L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
antimycobacterial
methyl
antimycobacterial pharmaceutical
composition
Prior art date
Application number
NO20065725A
Other languages
English (en)
Norwegian (no)
Inventor
Neelima Sinha
Ram Shankar Upadhayaya
Sundershan Kumar Arora
Rakesh Kumar Sinha
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of NO20065725L publication Critical patent/NO20065725L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20065725A 2004-05-12 2006-12-12 En antimycobakteriell farmasoytisk sammensetning. NO20065725L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (en) 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Publications (1)

Publication Number Publication Date
NO20065725L true NO20065725L (no) 2006-12-12

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065725A NO20065725L (no) 2004-05-12 2006-12-12 En antimycobakteriell farmasoytisk sammensetning.

Country Status (45)

Country Link
US (1) US7491721B2 (is)
EP (1) EP1750765B1 (is)
JP (1) JP2007537242A (is)
KR (1) KR100854309B1 (is)
CN (1) CN1956732B (is)
AP (1) AP1994A (is)
AR (1) AR048948A1 (is)
AT (1) ATE373488T1 (is)
AU (1) AU2004319259A1 (is)
BR (1) BRPI0418770A (is)
CA (1) CA2566440C (is)
CR (1) CR8748A (is)
DE (1) DE602004009113T2 (is)
DK (1) DK1750765T3 (is)
DO (1) DOP2005000085A (is)
EA (1) EA009694B1 (is)
EC (1) ECSP066965A (is)
ES (1) ES2294577T3 (is)
GE (1) GEP20094805B (is)
HK (1) HK1098962A1 (is)
HN (1) HN2005000210A (is)
HR (1) HRP20070574T3 (is)
IL (1) IL178858A (is)
IS (1) IS8559A (is)
JO (1) JO2471B1 (is)
MA (1) MA28603B1 (is)
MX (1) MXPA06012984A (is)
MY (1) MY139187A (is)
NI (1) NI200600270A (is)
NO (1) NO20065725L (is)
NZ (1) NZ550892A (is)
PA (1) PA8633001A1 (is)
PE (1) PE20060353A1 (is)
PL (1) PL1750765T3 (is)
PT (1) PT1750765E (is)
RS (1) RS20060624A (is)
SA (1) SA05260130B1 (is)
SI (1) SI1750765T1 (is)
SM (1) SM200500011B (is)
SV (1) SV2006002109A (is)
TN (1) TNSN06349A1 (is)
UA (1) UA82782C2 (is)
UY (1) UY28893A1 (is)
WO (1) WO2005107809A2 (is)
ZA (1) ZA200608843B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604388A1 (en) * 2005-04-11 2006-10-19 Lupin Limited Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗xdr−tb薬、抗mdr−tb薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
JP2013504591A (ja) * 2009-09-11 2013-02-07 バーテックス ファーマシューティカルズ インコーポレイテッド N−ベンジル−3−(4−クロロフェニル)−2−[メチル−[2−オキソ−2−(3,4,5−トリメトキシフェニル)アセチル]アミノ]−n−[3−(4−ピリジル)−1−[2−(4−ピリジル)エチル]プロピル]プロパンアミドの組成物およびその使用
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
AP1979A (en) * 2002-09-20 2009-03-20 Lupin Ltd Pyrrole derivatives as antimycobacterial compounds

Also Published As

Publication number Publication date
JO2471B1 (en) 2009-01-20
UA82782C2 (uk) 2008-05-12
CA2566440C (en) 2009-08-04
AU2004319259A1 (en) 2005-11-17
EA009694B1 (ru) 2008-02-28
JP2007537242A (ja) 2007-12-20
PA8633001A1 (es) 2006-12-07
CN1956732A (zh) 2007-05-02
PT1750765E (pt) 2007-12-31
MA28603B1 (fr) 2007-05-02
DK1750765T3 (da) 2008-01-28
IS8559A (is) 2006-10-26
BRPI0418770A (pt) 2007-10-09
CN1956732B (zh) 2010-04-28
KR20070007920A (ko) 2007-01-16
EA200601952A1 (ru) 2007-02-27
WO2005107809A3 (en) 2006-01-26
EP1750765B1 (en) 2007-09-19
IL178858A (en) 2010-06-16
EP1750765A2 (en) 2007-02-14
GEP20094805B (en) 2009-10-26
PL1750765T3 (pl) 2008-02-29
MXPA06012984A (es) 2007-04-23
RS20060624A (en) 2008-09-29
SI1750765T1 (sl) 2008-04-30
PE20060353A1 (es) 2006-07-08
WO2005107809A8 (en) 2006-05-18
DOP2005000085A (es) 2007-01-15
ZA200608843B (en) 2008-07-30
US20050256128A1 (en) 2005-11-17
NI200600270A (es) 2007-12-11
HRP20070574T3 (en) 2008-01-31
DE602004009113D1 (de) 2007-10-31
AP1994A (en) 2009-04-09
ATE373488T1 (de) 2007-10-15
SV2006002109A (es) 2006-04-18
AR048948A1 (es) 2006-06-14
IL178858A0 (en) 2007-03-08
ES2294577T3 (es) 2008-04-01
US7491721B2 (en) 2009-02-17
AP2006003807A0 (en) 2006-12-31
CR8748A (es) 2008-06-02
HK1098962A1 (en) 2007-08-03
KR100854309B1 (ko) 2008-08-26
HN2005000210A (es) 2009-03-17
SM200500011A (it) 2005-11-16
UY28893A1 (es) 2005-12-30
CA2566440A1 (en) 2005-11-17
NZ550892A (en) 2009-12-24
SM200500011B (it) 2005-11-16
TNSN06349A1 (en) 2008-02-22
ECSP066965A (es) 2006-12-20
DE602004009113T2 (de) 2008-06-19
WO2005107809A2 (en) 2005-11-17
SA05260130B1 (ar) 2008-05-04
MY139187A (en) 2009-08-28

Similar Documents

Publication Publication Date Title
NO20065725L (no) En antimycobakteriell farmasoytisk sammensetning.
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
CA2515726C (en) Isoxazole compounds
NO20073405L (no) Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning
HK1132260A1 (en) 1-(benzo [d] [1,3] di0x0l-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
GEP20125456B (en) Azetidines as mek inhibitors for the treatment of proliferative diseases
NO20051893L (no) Ny forbindelse
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20065873L (no) 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner
NO20065030L (no) Aerosolformulering for inhalering av beta agonister.
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20064074L (no) Pyrrolokinolin- og piperidinokinolinderivater, fremstilling derav, sammensetninger inneholdende disse og anvendelse derav
DE69900961T2 (de) Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE602005010725D1 (de) Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür
CU20060213A7 (es) Una composición farmacéutica antimicobacteriana
WO2023235837A3 (en) 4-(3h-pyrazolo[4,3-f]quinolin-7-yl)-n-(2-(dimethylamino)ethyl)benzamide- or hydroxamic acid compounds, compositions, and methods of use
SE0400968D0 (sv) Aryl glycine ether derivatives and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application